Showing results (821-830 of 6,672) with videos related to
Sort By:
Pageof 668
Neurobiology of Disease|August 8, 2007
Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal ratSilvia Carloni, Andrea Carnevali, Mauro Cimino, et al.Neurobiology of Disease|November 21, 2007
Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer's diseaseMilena Damjanac, Agnès Rioux Bilan, Marc Paccalin, et al.Neurobiology of Disease|March 3, 2007
Adult-onset hypothyroidism facilitates and enhances LTD: reversal by chronic nicotine treatmentK H Alzoubi, A M Aleisa, K A AlkadhiNeurobiology of Disease|February 13, 2007
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHDXueliang Fan, Ellen J HessNeurobiology of Disease|February 13, 2007
Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brainsLori-Ann Christie, Joseph H Su, Christina H Tu, et al.Neurobiology of Disease|April 3, 2007
Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolismSaravanan S Karuppagounder, Qingli Shi, Hui Xu, et al.Neurobiology of Disease|February 6, 2007
Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strainJeremy M Van Raamsdonk, Martina Metzler, Elizabeth Slow, et al.Neurobiology of Disease|January 24, 2007
The vacuolar-ATPase inhibitor bafilomycin and mutant VPS35 inhibit canonical Wnt signalingAna George, Hannah Leahy, Jianhua Zhou, et al.Neurobiology of Disease|October 28, 2006
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcoholJosé Antonio López-Moreno, Gustavo González-Cuevas, Miguel NavarroNeurobiology of Disease|October 28, 2006
Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotectionRachel Karlnoski, Donna Wilcock, Chad Dickey, et al.Pageof 668